Telitacicept Clinical Trials
12 recruitingDrug
Phase 35Phase 23Phase 43Not Applicable1
Showing 1–12 of 12 trials
Recruiting
Phase 3
A Study of Telitacicept in Patients With Ocular Myasthenia Gravis (OMG)
Myasthenia Gravis, Ocular
RemeGen Co., Ltd.120 enrolled1 locationNCT07249632
Recruiting
Phase 3
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Primary Sjogren's Disease
Vor Biopharma250 enrolled5 locationsNCT07404865
Recruiting
Phase 2
The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
Nanjing University School of Medicine50 enrolled1 locationNCT07340463
Recruiting
Phase 3
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
Generalized Myasthenia Gravis
Vor Biopharma180 enrolled84 locationsNCT06456580
Recruiting
Phase 2
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
ThrombocytopeniaConnective Tissue Diseases
Beijing Hospital296 enrolled23 locationsNCT05998759
Recruiting
Phase 2
Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis
Diffuse Cutaneous Systemic Sclerosis
Second Affiliated Hospital, School of Medicine, Zhejiang University38 enrolled9 locationsNCT06375005
Recruiting
Phase 3
Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome
Nephrotic Syndrome in ChildrenTelitacicept
The Children's Hospital of Zhejiang University School of Medicine20 enrolled1 locationNCT06125405
Recruiting
Phase 4
The Safety and Efficacy of Telitacicept in the Treatment of Systemic Sclerosis
Systemic Sclerosis
Peking University Third Hospital20 enrolled1 locationNCT06546540
Recruiting
Not Applicable
Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients
Systemic Lupus Erythematosus
RenJi Hospital176 enrolled1 locationNCT06394063
Recruiting
Phase 3
Efficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Liu Tian60 enrolled1 locationNCT05339217
Recruiting
Phase 4
Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)
Maintenance TherapyANCA-associated Vasculitis
Chinese SLE Treatment And Research Group40 enrolled1 locationNCT05965284
Recruiting
Phase 4
Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM)
Chinese SLE Treatment And Research Group40 enrolled1 locationNCT05962840